Envoy Medical
COCH
21 hedge funds and large institutions have $41.1M invested in Envoy Medical in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 8 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
85.35% more ownership
Funds ownership: 9.67% → 95.03% (+85%)
1% less capital invested
Capital invested by funds: $41.3M → $41.1M (-$210K)
13% less funds holding
Funds holding: 24 → 21 (-3)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSU
Mizuho Securities USA
New York
|
+$2.44M |
| 2 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
+$1.9M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.64M |
| 4 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
+$1.21M |
| 5 |
SG
StoneX Group
New York
|
+$253K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.76M |
| 2 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$1.6M |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$1.21M |
| 4 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$1.21M |
| 5 |
ASM
ATW SPAC Management
New York
|
-$1M |
COCH Hedge Fund Activity: Q2 2023 in Review
21 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q2 2023, worth a combined $41.1M — down 0.51% from $41.3M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of COCH and 5 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was Mizuho Securities USA, opening a new position worth an estimated $2.44M. The largest seller was Citadel Advisors, exiting entirely with an estimated $1.76M sold.
- 21 institutional investors held Envoy Medical (COCH) as of Q2 2023, down from 24 in Q1 2023.
- Funds reported $41.1M of Envoy Medical stock for Q2 2023, down 0.51% quarter-over-quarter.
- 5 funds opened new Envoy Medical positions in Q2 2023 and 8 closed out, a net change of -3 holders.
- The largest Envoy Medical buyer in Q2 2023 was Mizuho Securities USA, an estimated $2.44M added.
- The largest Envoy Medical seller in Q2 2023 was Citadel Advisors, an estimated $1.76M sold.
Based on aggregated 13F filings for Q2 2023.